Satish Chitneni to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Satish Chitneni has written about Xenograft Model Antitumor Assays.
Connection Strength
0.213
-
Observations on the Effects of Residualization and Dehalogenation on the Utility of N-Succinimidyl Ester Acylation Agents for Radioiodination of the Internalizing Antibody Trastuzumab. Molecules. 2019 Oct 30; 24(21).
Score: 0.152
-
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma. Clin Cancer Res. 2018 08 01; 24(15):3611-3631.
Score: 0.034
-
Copper signaling axis as a target for prostate cancer therapeutics. Cancer Res. 2014 Oct 15; 74(20):5819-31.
Score: 0.027